Search

Showing total 2 results
2 results

1. ARVO: Sight set on world-class science.

Subjects
*THERAPEUTIC use of antioxidants, *RETINAL degeneration, *HETEROCYCLIC compounds, *OPHTHALMOLOGY, *CONFERENCES & conventions, *DRY eye syndromes, *ENZYME inhibitors, *GLAUCOMA, *MICROSCOPY, *OPHTHALMIC drugs, *PROTEINS, *RETINAL diseases, *TEARS (Body fluid), *PREVENTION, *SOCIETIES
Abstract

Information about several papers discussed at the Association for Research in Vision and Ophthalmology (ARVO) meeting in 2013 is presented. Age-Related Eye Disease Study 2 (AREDS2) results showed that participants treated with the antioxidants lutein and zeaxanthin without beta-carotene had their risk of age-related macular degeneration (AMD) reduced at about 18%. Automated standardization in evaluating corneal superficial punctuate keratitis (SPK) is shown not to be invariably applicable.

Published
2013

2. EXPERT CONSENSUS IN THE TREATMENT OF DRY EYE INFLAMMATION.

Subjects
CONFERENCES & conventions, SPECIALISTS, EYE inflammation, DRY eye syndromes, OPHTHALMOLOGY
Abstract

Information about several topics discussed at a symposium held during the 2006 American Academy of Ophtalmology Joint Meeting concerning the treatment of dry eye inflammation is presented. The background of dry eye inflammation, its syndrome, and how it affects the life quality of an individual is described. Theories on the causes, nature, and the effects of the disease which lead to newer treatment approaches are also presented.

Published
2007